Kepos Capital’s Merck MRK Stock Holding History

Kepos Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-283	Closed	-$37K	–	245
2024 Q1	$37K	Buy	+283	New	+$34.9K	0.01%	211
2022 Q4	$36K	Buy	+324	New	+$33.1K	0.01%	279
2020 Q1	–	Sell	-4,611	Closed	-$400K	–	261
2019 Q4	$400K	Buy	+4,611	New	+$379K	0.04%	252
2019 Q3	–	Sell	-31,362	Closed	-$2.51M	–	372
2019 Q2	$2.51M	Sell	31,362 -45,051	-59%	-$3.45M	0.25%	91
2019 Q1	$6.06M	Buy	76,413 +3,196	+4%	+$239K	0.45%	62
2018 Q4	$5.34M	Buy	+73,217	New	+$5.17M	0.41%	77
2018 Q3	–	Sell	-16,583	Closed	-$960K	–	398
2018 Q2	$960K	Buy	+16,583	New	+$936K	0.05%	225
2017 Q4	–	Sell	-5,613	Closed	-$343K	–	188
2017 Q3	$343K	Buy	+5,613	New	+$340K	0.06%	93

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kepos Capital's MRK Position: Q2 2024 in Review

Kepos Capital sold out of Merck (MRK) in Q2 2024, closing a stake of 283 shares — an estimated $37K sold.

Kepos Capital first reported a position in MRK in Q3 2017 and held it in 8 quarters. The position peaked at $6.06M in Q1 2019. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Kepos Capital reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
Kepos Capital sold 283 Merck shares in Q2 2024, an estimated $37K.
Kepos Capital first reported a position in Merck in Q3 2017 and held it in 8 quarters.
Kepos Capital's Merck position peaked at $6.06M in Q1 2019.
3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Kepos Capital's 13F filing for Q2 2024, filed 13 Aug 2024.